News for 'US Food and Drug Administration'

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

Hand over central lab report to J&J: HC tells Maha

Hand over central lab report to J&J: HC tells Maha

Rediff.com27 Oct 2022

A vacation bench of Justices NJ Jamadar and Sharmila Deshmukh passed the decision on Wednesday while hearing a petition filed by the company challenging two orders of the state government.

Wockhardt to recall some drugs made in India

Wockhardt to recall some drugs made in India

Rediff.com28 Apr 2015

Wockhardt is recalling select drugs in the US, which were under import restrictions from the USFDA.

Madhuri Dixit gets FDA notice for endorsing Maggi

Madhuri Dixit gets FDA notice for endorsing Maggi

Rediff.com29 May 2015

If the actress fails to respond to the notice within the stipulated time frame, a case could be registered against her, Food Security Officer Mahimanand Joshi said.

US drug regulator finds Indian companies critically ill

US drug regulator finds Indian companies critically ill

Rediff.com24 Sep 2013

The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.

Maharashtra asks Snapdeal to stop selling prescription drugs

Maharashtra asks Snapdeal to stop selling prescription drugs

Rediff.com18 Apr 2015

Flipkart, Amazon, too, under radar

Trump threatens steeper tariffs on India over Russian oil buy

Trump threatens steeper tariffs on India over Russian oil buy

Rediff.com4 Aug 2025

"India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump said in a social media post on Monday.

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Rediff.com16 Apr 2014

Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

Rediff.com28 Dec 2021

The emergency use of the drug will be for adult COVID-19 patients with SpO2 93 percent and who have a high risk of progression of the disease including hospitalisation or death subject to certain conditions

Drug regulator to make routine inspection of Chinese suppliers

Drug regulator to make routine inspection of Chinese suppliers

Rediff.com15 Nov 2013

Move follows a spate of international regulatory enforcements on Indian drug firms.

Maha cancels Johnson & Johnson's baby powder manufacturing licence

Maha cancels Johnson & Johnson's baby powder manufacturing licence

Rediff.com17 Sep 2022

Samples of the powder for babies did not conform to standard pH value during a laboratory test, the regulator said.

US drug regulator warns RPG Life Sciences

US drug regulator warns RPG Life Sciences

Rediff.com19 Jun 2013

The US Food and Drug Administration (USFDA) has issued a warning letter to RPG Life Sciences for violation of current good manufacturing practice (CGMP) norms at its two plants at Ankleshwar and Mumbai.

FSSAI launches probe into MDH and Everest products

FSSAI launches probe into MDH and Everest products

Rediff.com23 Apr 2024

The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.

Anti-malarial drug a 'line of defence' against virus: Trump

Anti-malarial drug a 'line of defence' against virus: Trump

Rediff.com20 May 2020

The US president said the drug has gotten a bad reputation only because 'he was promoting it'.

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Rediff.com2 May 2014

Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging.

USFDA warns Aurobindo Pharma

USFDA warns Aurobindo Pharma

Rediff.com23 May 2011

Company had earlier received an import alert in February this year from the US Food and Drug Administration.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin recalls 9,210 bottles of anti-infective drug from the US

Rediff.com15 Apr 2014

The recent recalls come amid increased FDA scrutiny of medicines produced in India.

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Rediff.com9 Apr 2014

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments

Taking anti-malarial drug to protect against virus: Trump

Taking anti-malarial drug to protect against virus: Trump

Rediff.com19 May 2020

Soon after Trump revealed to the world that he has been taking the medicine, the White House doctor said the president is in good health.

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Rediff.com3 Oct 2023

India's pharmaceutical exports to Iran have been hit owing to depleting rupee reserves in the West Asian country because of India stopping the import of crude oil from it in 2019 following US sanctions. Pharmaceutical exports dropped 71.25 per cent in April-August this year over the same period last year. The data from the Pharmaceutical Exports Promotion Council (Pharmexcil) showed exports to Iran had declined 31.29 per cent in 2022-23 as against the previous financial year.

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

As domestic sales decline, drug makers focus on exports

As domestic sales decline, drug makers focus on exports

Rediff.com1 Oct 2020

While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.

Trump warns India of retaliation if it doesn't allow export of drug

Trump warns India of retaliation if it doesn't allow export of drug

Rediff.com7 Apr 2020

The US president said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

Notice to ayurvedic drugs firm for misleading Covid claims

Notice to ayurvedic drugs firm for misleading Covid claims

Rediff.com20 Apr 2021

The company claimed that its product is "three times better than remdesivir and that 'AAYUDH Advance starts where vaccines stop'."

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

Lupin gets USFDA nod to market HIV drug in US

Lupin gets USFDA nod to market HIV drug in US

Rediff.com10 Dec 2013

The company has received final approval from the US Food and Drug Administration for its Abacavir Sulfate Lamivudine, and Zidovudine Tablets, Lupin Ltd said in a statement.

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Rediff.com4 Mar 2023

Rathod said the Maharashtra government had initiated an inquiry against 84 out of 108 manufacturers of cough syrups in the state.

A bitter pill for Aurobindo's sterile drug unit

A bitter pill for Aurobindo's sterile drug unit

Rediff.com25 Nov 2019

USFDA issues Form 483 with as many as 14 observations that could impact ongoing operations at Aurobindo's Pashamailaram facility in Hyderabad.

Want To Invest In Pharma & Healthcare?

Want To Invest In Pharma & Healthcare?

Rediff.com5 Nov 2024

'A long-term investor with a 4 to 5 year horizon could invest in this theme via SIPs.'

USFDA pulls up Sun Pharma for lapses in Halol plant

USFDA pulls up Sun Pharma for lapses in Halol plant

Rediff.com14 Jan 2023

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant. In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products. "This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals... Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," the USFDA stated.

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Be a good neighbour, don't stoke fire of hatred: Manipur slams Mizoram CM

Rediff.com30 Nov 2024

The Manipur government has accused Mizoram Chief Minister Lalduhoma of stoking hatred and division through "unwarranted comments" and called on him to display "better statesmanship" by being a "good neighbour". In a statement, the Manipur government alleged that Lalduhoma's comments were part of a "greater agenda" to carve out a Kuki-Chin Christian nation from contiguous areas of Myanmar, India, and Bangladesh. It also warned against any attempt to "push" illegal Kuki-Chin immigrants from Mizoram into Manipur for land grabbing and the creation of a "Greater Mizoram." The Mizoram government could not be reached immediately for comment.

FDA finds contaminated drug ingredient at GSK Ireland plant

FDA finds contaminated drug ingredient at GSK Ireland plant

Rediff.com2 Apr 2014

The FDA has stepped up its efforts to ensure drug safety in recent months.

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Rediff.com22 Oct 2013

The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Trump's tariffs: How will these sectors in India be impacted?

Trump's tariffs: How will these sectors in India be impacted?

Rediff.com2 Apr 2025

Goods from sectors, including agriculture, precious stones, chemicals, pharma, medical devices, electricals, and machinery may get impacted if the US will go ahead with imposing reciprocal tariffs on Indian products, according to experts. They said that these sectors could face additional customs duties from the Trump administration because of the high tariff differential or gap, which is the difference between the import duties imposed by the US and India on a product.

Maggi issue: Will food regulator move the Supreme Court?

Maggi issue: Will food regulator move the Supreme Court?

Rediff.com18 Aug 2015

The court had provided a conditional relief to Nestle India.

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Rediff.com11 Jun 2024

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. According to the latest data from US-based Centers for Medicare and Medicaid Services (CMMS), price erosion in calendar year 2024 (CY24) on a year-to-date (YTD) basis stood at a high of 15 per cent in the oral solid dosage (OSD) segment compared to a low of 1 per cent in CY23. This erosion, according to a report by Antique Stock Broking, was the highest in the last three years.